LGND 股东权益历史(2016–2025)
LIGAND PHARMACEUTICALS INC (LGND) 各财年年末股东权益(来自 SEC 财报)。
$1.0BFY2025 · FY2016 以来:$341.3M → $1.0B
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $1.0B | +22.5% |
| FY2024 | $830.4M | +18.5% |
| FY2023 | $700.9M | +17.3% |
| FY2022 | $597.5M | -27.2% |
| FY2021 | $821.2M | +15.7% |
| FY2020 | $709.5M | -7.5% |
| FY2019 | $767.2M | +36.8% |
| FY2018 | $560.9M | +40.3% |
| FY2017 | $399.8M | +17.1% |
| FY2016 | $341.3M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议